Glaucoma management can be complicated and expensive. OMNI improves the patient experience by offering personalized formulations that are simpler to dose than the standard multi-drop treatment plan. Our formulations combine as many as four medications into a single drop to help remove barriers to use, promote adherence and reduce out-of-pocket expenses for patients. OMNI drops ship directly to your practice or patient’s home at no added cost. How to begin prescribing.
Timolol 0.5%
Latanoprost 0.005%
Sterile Ophthalmic Solution
3.5 mL
Timolol 0.5%
Brimonidine Tartrate 0.2%
Dorzolamide 2%
Sterile Ophthalmic Solution
3.5 mL
Timolol 0.5%
Brimonidine Tartrate 0.2%
Dorzolamide 2%
Latanoprost 0.005%
Sterile Ophthalmic Solution
3.5 mL
In a prospective multicenter trial, the combination of timolol maleate 0.5%, brimonidine tartrate 0.2%, dorzolamide hydrochloride 2% and latanoprost 0.005% was shown to be safe and therapeutically equivalent to conventional multiple medication therapy in the context of primary open-angle glaucoma. View the full study here.